Bank of New York Mellon »

Akero Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 189k 25.26
2023-12-31 $4.2M 178k 23.35
2023-09-30 $25M 500k 50.58
2023-06-30 $7.2M 154k 46.69
2023-03-31 $4.7M 123k 38.26
2022-12-31 $7.7M 141k 54.80
2022-09-30 $3.8M 113k 34.02
2022-06-30 $814k 86k 9.46
2022-03-31 $1.2M 82k 14.18
2021-12-31 $1.7M 79k 21.16
2021-09-30 $1.7M 77k 22.36
2021-06-30 $1.7M 70k 24.80
2021-03-31 $1.6M 55k 29.00
2020-12-31 $1.6M 60k 25.81
2020-09-30 $2.2M 71k 30.81
2020-06-30 $1.0M 41k 24.95
2020-03-31 $580k 28k 21.10
2019-12-31 $422k 19k 22.22
2019-09-30 $251k 11k 22.84